Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mabpharm Limited Board/Management Information 2019

May 30, 2019

50428_rns_2019-05-29_2d302453-9832-4fc8-b932-45d289889fd0.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [73 x 86] intentionally omitted <==

Mabpharm Limited 邁博藥業有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2181)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

The members of the board (the “ Board ”) of directors (the “ Director(s) ”) of Mabpharm Limited (the “ Company ”) are set out below:

Executive Directors

Dr. Qian Weizhu (Chief Executive Officer)

Dr. Wang Hao

Mr. Li Yunfeng

Dr. Li Jing

Non-executive Directors

Mr. Jiao Shuge (Chairman)

Mr. Guo Jianjun

Independent Non-executive Directors

Mr. Guo Liangzhong

Dr. Zhang Yanyun

Dr. Liu Linqing

– 1 –

The Board has set up three committees with defined terms of reference. The membership information of these committees is set out below.

Audit Committee

Dr. Liu Linqing (Chairman)

Mr. Jiao Shuge

Mr. Guo Liangzhong

Remuneration Committee

Dr. Zhang Yanyun (Chairman)

Dr. Wang Hao

Mr. Guo Liangzhong

Nomination Committee

Mr. Guo Liangzhong (Chairman)

Dr. Qian Weizhu

Dr. Zhang Yanyun

Hong Kong, May 30, 2019

– 2 –